Besides the issues, where is the trend going in microfluidics?
Blanco: One of the trends is incorporating syndromic MDx analyzers with better clinical outputs. Thanks to our clinical research activity, we are monitoring the introduction of many clinical trials to introduce novel multiplex molecular diagnostic test, that will serve as a platform for testing respiratory diseases (COVID, Flu A and B, and other respiratory panels), STDs and other complex panels in one device. The advantages are substantial for the patient and for the healthcare systems.
In other segments like next-generation sequencing (NGS), cell analysis microfluidics is being established as the gold standard to simplify workflows and to make these new technologies accessible to the laboratories and clinics around the world. The healthcare systems are seeking faster quality responses, more clinical value, more automation and to be close to the patient. This is one of the drivers that is moving the industry and microfluidic solutions are helping many customers to improve healthcare outcomes using these innovative products.
TE is an exhibitor at COMPAMED, what new products will you have in your luggage?
Blanco: TE is exhibiting at both COMPAMED (Hall 8a / H29) and MEDICA (Hall 3 / C40-6). We have experts available to talk about services and products we provide, such as NPD, usability, regulatory, clinical research and manufacturing. At the show we plan to highlight our capabilities in:
- Manufacturing of point of care (POC) IVD products integrating excellent reagent technologies (new blister design, lyophilization) to improve workflow automation to our customers
- Manufacturing of high-resolution microfluidic devices (with resolution of 1 micron) based on stellar microfluidic technologies specific for NGS, Single Cell Analysis and other challenging and exciting applications that demand this kind of great industrial resolution
- The launch of two new, advanced, microfluidic factories in Europe and the US that position TE as the preferred supply chain provider for customers
- New offerings in the Dx space for new product development, usability, clinical research and regulatory services in Europe to support customers in IVDR